Poeschl Paul W, Ziya-Ghazvini Farzad, Schicho Kurt, Buchta Christoph, Moser Doris, Seemann Rudolf, Ewers Rolf, Schopper Christian
Department of Craniomaxillofacial and Oral Surgery, Medical University of Vienna, Vienna, Austria.
J Oral Maxillofac Surg. 2012 Mar;70(3):657-64. doi: 10.1016/j.joms.2011.04.027. Epub 2011 Aug 15.
The present study was conducted to evaluate the effect of platelet-rich plasma (PRP) on new bone formation and remodeling after grafting of the maxillary sinus with an algae-derived hydroxyapatite AlgOss/C Graft/Algipore.
Fourteen consecutive patients with severely atrophic maxillae underwent uni- or bilateral grafting of the maxillary sinus with a mixture of collected bone, algae-derived hydroxyapatite AlgOss/C Graft/Algipore (ratio 1:10), and a combined addition of PRP and thrombin (Tissucol Kit; Baxter, Vienna, Austria) to allow for fast clotting. After an average healing period of 7.1 months bone samples were retrieved. Patients from a former consecutive series treated without PRP served as control group. Statistical analysis was done by Welch 2-sample t test and mixed linear model testing.
In the coronal specimen portions, mean values for newly formed bone area, biomaterial area and marrow space of 32.2% ± 10.4%, 20.1% ± 13.0%, and 47.7% ± 8.5% were found with PRP, respectively. In the control group the corresponding values were 27.6% ± 13.4%, 20.3% ± 12.9%, and 52.1% ± 9.3%. In the apical specimen portions in the PRP group, the newly formed bone area, biomaterial area, and marrow space was 25.7% ± 15.0%, 23.4% ± 14.9%, and 50.9% ± 12.5%, respectively. The corresponding values in the control group were 17.0% ± 8.6%, 34.5% ± 11.2%, and 48.5% ± 8.5%.
Statistical evaluation of the samples proved significantly better overall resorption of algae-derived hydroxyapatite AlgOss/C Graft/Algipore and increased new bone formation when PRP was used, especially in the apical region.
本研究旨在评估富血小板血浆(PRP)对上颌窦采用藻类衍生羟基磷灰石AlgOss/C移植物/Algipore移植后新骨形成和重塑的影响。
14例连续性严重萎缩上颌骨患者接受单侧或双侧上颌窦移植,移植材料为采集的骨、藻类衍生羟基磷灰石AlgOss/C移植物/Algipore(比例1:10),并联合添加PRP和凝血酶(Tissucol套件;奥地利维也纳百特公司)以促进快速凝血。平均愈合7.1个月后获取骨样本。将之前连续系列未使用PRP治疗的患者作为对照组。采用韦尔奇两样本t检验和混合线性模型检验进行统计分析。
在冠状标本部分,使用PRP时新形成骨面积、生物材料面积和骨髓腔的平均值分别为32.2%±10.4%、20.1%±13.0%和47.7%±8.5%。对照组相应值分别为27.6%±13.4%、20.3%±12.9%和52.1%±9.3%。在PRP组根尖标本部分,新形成骨面积、生物材料面积和骨髓腔分别为25.7%±15.0%、23.4%±14.9%和50.9%±12.5%。对照组相应值分别为17.0%±8.6%、34.5%±11.2%和48.5%±8.5%。
样本的统计评估证明,使用PRP时藻类衍生羟基磷灰石AlgOss/C移植物/Algipore的总体吸收明显更好,新骨形成增加,尤其是在根尖区域。